Blogs
A Look at AstraZeneca Price Targets -- Seeking Alpha
<strong><a href='http://pulse.alacra.com/blog/'>Alacra Pulse Check Blog</a>submits:</strong><p><em><span>By<span>Karen Schwartz</span></span></em><span></p><div><div><div><div><p><img src="http://static.seekingalpha.com/uploads/2010/10/17/saupload_azn_logo1.png" align="right" hspace="6" vspace="6"
Big Pharma become Team Pharma
Home | Contact Us | Advertise | About Us | Privacy Policy | News Archive Medicine Politics Practice Ideas Other stuff Jobs Search [BLOG HOMEPAGE] Big Pharma become Team Pharma By Michael Woodhead,
Januvia Linked to Pancreatitis by FDA - Health Blog - WSJ
An FDA notice on Merck's Januvia comes just over a year after Byetta was also linked to pancreatitis.
Generic prescribing should be protocol, say recommendations — Irish Medical Times
February 3, 2012 Home Contact Us About Us Subscribe Advertising Terms of Use Privacy Policy Sitemap RSS Feeds Irish Medical Times News Opinion Features Editorial Letters Blogs Clinical Times MIMS Ireland Lifestyle Jobs Events Small ads You are here: Home / Blogs / Hospital Medicine / Generic
Blog. The Global Challenge of Infectious Disease
Posted by Ben Hewett on November 13, 2008 at 12:43 pm[pg] [pg] The talk of the town since the conclusion of this historic election has been understandably focused on on how to fix the economy, pull ou
Dean Baker: Promises to the Drug Industry: Like Renegotiating NAFTA?
The government is giving the drug companies incentives to promotes their drugs even when they aren't the best medicine for patients. This goes directly against efforts to contain costs by promoting good medicine.
Merck / J&J Rheumatoid Arthritis Drug Arbitration Delayed: What's at Stake? -- Seeking Alpha
<strong><a href='http://www.pharmalot.com/'>Pharmalot</a>submits:</strong><p>The closely watched dispute between Merck (<a href='http://seekingalpha.com/symbol/mrk' title='Merck& Co. Inc.'>MRK</a>) and Johnson& Johnson (<a href='http://seekingalpha.com/symbol/jnj' title='Johnson&
Pfizer Picks Ups King in Expansion of Pain Franchise -- Seeking Alpha
<strong><a href='http://www.burrillreport.com/'>The Burrill Report</a>submits:</strong><p><em>By Michael Fitzhugh</em></p><p>Pfizer (<a href='http://seekingalpha.com/symbol/pfe' title='Pfizer Inc.'>PFE</a>), the world’s largest pharmaceutical company, is moving to bolster its pain medications
A Third Mega-Deal Done, Pfizer Still Needs New Drugs -- Seeking Alpha
<strong><a href='http://www.trefis.com/splash?to=/'>Trefis</a>submits:</strong><div><p>Pfizer (<a href='http://seekingalpha.com/symbol/pfe' title='Pfizer Inc.'>PFE</a>) paid $90 billion for Warner Lambert a decade ago, then added Pharmacia, at a cost of $60 billion, about three years later, and
Pfizer Beefs Up Pain Portfolio With King Pharma Buy -- Seeking Alpha
<strong><a href='http://www.pharmalot.com/'>Pharmalot</a>submits:</strong><p>In the latest example of how Pfizer (<a href='http://seekingalpha.com/symbol/pfe' title='Pfizer Inc.'>PFE</a>) is trying to become a Hollywood-like conglomerate, the drugmaker has agreed to pay $3.6 billion to buy King
Refine by Topic:
Refine by Content Type:
Refine by Source:
- seekingalpha.com (431)
- www.genengnews.com (10)
- www.imt.ie (2)
- blogs.wsj.com (1)
- www.6minutes.com.au (1)
- www.huffingtonpost.com (1)
